Navigation Links
Heart-Pacing Devices Hold Promise for Heart Failure
Date:10/1/2009

Defibrillators, pacemakers offer benefits for patients with milder forms of the condition, study suggests

THURSDAY, Oct. 1 (HealthDay News) -- New research provides more evidence that a new type of pacemaker/defibrillator technology may be a good option for patients with mild forms of heart failure.

An international team of researchers reports that the kind of heart "pacing" provided by new defibrillators and pacemakers can help these patients. But the research still needs to be confirmed before doctors begin embracing its findings, said a cardiologist familiar with the research.

The technology in question "is expensive, resource-intensive, and associated with increased risk of complications compared with less complex devices," explained Dr. Jeptha Curtis, an assistant professor of medicine at the Yale University School of Medicine.

Heart failure occurs when the heart fails to pump blood properly, often as a result of heart attacks, and affects an estimated 5.7 million Americans. "Patients often feel fatigue, as well as shortness of breath from fluid building up in the lungs and swelling of the legs from fluid building up there as well," said Dr. Kevin Heist, a cardiac electrophysiologist at Massachusetts General Hospital.

Cardiac resynchronization therapy defibrillators, which shock the heart to return it to a normal rhythm, are used in some patients with advanced cases of heart failure. Pacemakers are also available with the technology, Heist said.

The devices control the left and right sides of the heart, which can improve heart failure symptoms like shortness of breath and fatigue, Heist said.

The new study, published online Sept. 30 in the Journal of the American College of Cardiology, looked at whether the kind of heart control used in some new defibrillators -- known as biventricular pacing -- would work in patients with milder cases of heart failure.

The researchers randomly assigned 262 patients with defibrillators or pacemakers to receive normal treatment with the devices or to have an extra "pacing" function turned on to help their hearts beat more properly. The patients who got the more expanded treatment did better and lived longer.

"However, the study is definitely not definitive, and we will need to see the results of similar, ongoing trials before we change practice," Curtis said.

One problem is that the research is part of a larger study that hasn't shown such a dramatic improvement in patients due to the technology, Curtis said.

"The reasons of this discrepancy are not clear, but it makes it that much more important that the results be confirmed before we start using this technology more aggressively," he said.

Heist, however, said another study came up with similar results.

Overall, only about 20 percent of patients whose lives may be improved by defibrillators actually get them, Heist said. "This is due to a combination of patient reluctance and lack of knowledge by referring physicians," he said. "Many lives could be saved if this rate could be improved."

More information

For more about heart failure, visit the American Heart Association.



SOURCES: Jeptha Curtis, M.D., assistant professor, medicine, Yale University School of Medicine, New Haven, Conn.; Kevin Heist, M.D., Ph.D., cardiac electrophysiologist, Massachusetts General Hospital, Boston; Sept. 30, 2009, Journal of the American College of Cardiology, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
2. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
3. FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
4. HealthShares(TM) Announces Change to the HealthShares(TM) Cardio Devices Index
5. Nationwide independent Taser study results suggest devices are safe
6. Brain measurements could lead to better devices to move injured or artificial limbs
7. Do women fare worse with some heart devices?
8. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes
9. DeviceSpace Career Fair Opens Doors for Hundreds of Medical Device and Diagnostics Career Candidates
10. Hazardous Advanced Micro Devices (A.M.D.) Clean Room Chemicals Caused Multiple Birth Defects, Lawsuit Alleges
11. SPO Medical Unveils New Oximetry Devices for European Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Doctor C LLC, a company based out of ... show to continue the marketing and distribution of its product, The Right C. , ... percent better absorption than traditional vitamin C supplements. At the trade show, Doctor C ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company ... bodybuilding supplements, announced it attended the January ECRM trade show in Hilton Head, SC. ... scientist who was determined to create a line of products that would elevate her ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More ... to the issue of world hunger, and shares the simple and achievable answer. “The ... husband and member of the Fairview Missionary Church in Angola, Indiana where he works ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor ... global anti-obesity drugs market is expected to grow at a ... and CAGR of 38.7% in the second half of the forecast ... 32.8% from 2016 to 2027. The market is estimated at $1,058 ... 2027. ...
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
(Date:1/19/2017)... 2017 ViewRay, Inc. (Nasdaq: VRAY) announced today that ... research in Germany , has purchased ... the University Clinic Heidelberg as part of its initiative ... program will be headed by Medical Director and Professor ... at the German Cancer Research Center (DKFZ), the Heidelberg ...
Breaking Medicine Technology: